- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 7.99M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 4.24M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.54M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.38K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.85M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$9.38M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.35M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.34M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $8.25M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $14.29M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.87M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.75M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.06M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $9.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $14.04M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.12M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $14.98M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.33 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$4.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.33 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$4.30 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.79M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.97M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.01M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.43M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.65M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.79M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.4M |